Monograph
A10BD05 - Metformin and Pioglitazone |
Propably not porphyrinogenic |
PNP |
Rationale
This combination product contains two substances: metformin (ATC code: A10B A02) and pioglitazone (ATC code: A10B G03). Metformin is safety classified as Not porphyrinogenic (NP) while pioglitazone is safety classified as Probably not porphyrinogenic (PNP). The classification of the combination is according to the most porphyrinogenic of the two substances. For more details please refer to the monographs of the two substances.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Netherlands
Competact · Competact 15 mg/850 mg, tablettenBelgium
Competact · Competact 15 mg - 850 mg compr. pellic.United Kingdom
Competact · Competact 15mg/850mg tablets · Metformin / Pioglitazone · Pioglitazone 15mg / Metformin 850mg tabletsDenmark
CompetactNorway
CompetactPoland
Competact · GlubravaLuxembourg
COMPETACTIceland
CompetactFinland
CompetactLatvia
Competact
© NAPOS 2024